JZP-110 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Narcolepsy
Conditions
Narcolepsy, Excessive Sleepiness
Trial Timeline
Jun 1, 2016 → May 19, 2019
NCT ID
NCT02806908About JZP-110 + Placebo
JZP-110 + Placebo is a phase 2 stage product being developed by Jazz Pharmaceuticals for Narcolepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT02806908. Target conditions include Narcolepsy, Excessive Sleepiness.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02806895 | Phase 2 | Completed |
| NCT02806908 | Phase 2 | Completed |
Competing Products
20 competing products in Narcolepsy